Biochemical processes initiated by estrogenic hormones in the organs which are not directly related to reproduction were described in the survey on the basis of literature and the authors' own studies. The importance of these compounds in the regulation of fundamental biological processes has been established in the last decades. The biochemical mechanisms of realization of estrogen effects may be considered as potential links of pathogenesis for a number of diseases and as targets of their therapy. k e y w o r d s: estrogens, biochemical mechanisms, non-reproductive organs, endocrine glands, brain, cardiovascular system.
Biochemical processes initiated by estrogenic hormones in the organs which are not directly related to reproduction were described in the survey on the basis of literature and the authors' own studies. The importance of these compounds in the regulation of fundamental biological processes has been established in the last decades. The biochemical mechanisms of realization of estrogen effects may be considered as potential links of pathogenesis for a number of diseases and as targets of their therapy. k e y w o r d s: estrogens, biochemical mechanisms, non-reproductive organs, endocrine glands, brain, cardiovascular system. E strogenic hormones have been considered for decades only as regulators of sexual func tions. But the facts have been accumulated, which evidence for the extreme importance of these compounds for the whole organism regardless of its genetic belonging to males or females. The work purpose is a brief survey of bichemical processes with participation of estrogens in the organs apart from the reproductive system.
Estrogens play the important part in regulation of physiological processes as well as in aging and pathology. Investigations have shown a fundamen tal role of estrogens in the activity of reproductive, cardiovascular, muscular, bone, nervous systems as well as in development of pathology in these sys tems, in oncopathology, in particular. Biochemical effects of estrogens are displayed both in genetically female and male organisms, though the character and expression of the effects may be essentially dif ferent. Estrogens are formed in the male organism in the adrenal cortex and testicles; transformation of testosteron and androstenedione by aromatase into estrogen in many tissues, in the fatty tissue, in par ticular, serves as the additional and maybe even the major source of estrogens in a quantitative sense [1] . The amount of synthesized estradiol (E2) increases in men with the growth of the mass of fatty tissue.
characteristic of fundamental processes of estrogens effect
The basic mechanisms of the effect of these hormones have been deciphered by the efforts of bio chemists and molecular biologists. Two main ways to realize their effect have been shown: genome and nongenome ones.
The genome way begins by coupling the es trogen molecules with nucleus receptors. Receptors of two types α and β have been found and studied. They are rather close as to their amino acid compo sition, coincide partially by physiological functions and distribution in tissues, but a number of effects realized with the help of these estrogenic receptors (ER) differs. These differences could be especially distinctly established, using the knockout methodo logy. In particular, complete infertility and distur bance of sexual behaviour are observed in male mice deprived of ERα. No fertility disturbances were ob served in males under ERβ knock-out [2] . Splicing variants of ER are also known which probably pos sess certain biological activity as well, but they are poorly studied.
ER genes were mapped, and it was shown that ERα is in a long chromosome 6 arm, while gene ERβ is in chromosome 14q 2224 [36] . The expression of ERα and ERβ differs [7] . ERα is expressed intensive doi: http://dx.doi.org/10.15407/ubj87.05.010 ly in the uterus, testicles, hypophysis and mammary glands, while ERβ is expressed to a higher extent in the brain, prostate, ovaries, lungs and adrenals [7, 8] . The expression of receptors is not interrelated.
Estrogen receptors are among the superfamily of nuclear hormonal receptors. ERα contains 595 amino acids [3] , and ERβ -530 amino acids [4] . Nuclear receptors of estrogens contain 6 functional domains [9] . Domains A and B being on the N-end are the most variable sites of the receptor, and isoforms α and β contain no more than 20% of homologic amino acids. A/B domains can activate the transcription even without binding to ligand (AF1). This function is specific to cells of various types and differs from the transcription activator AF2, located in domain E [10] . The central domain C ensures the receptor binding to DNA and dimerization. It is highly con servative: 95% of amino acids of α-and β-isoforms coincide. A highly conservative site of binding to DNA has 2 zinc digits, and that ensures ER contact with DNA. Domain D forms a loop. The domain is rather variable: homology does not exceed 30% and determine nuclear localization. Domain E binds a ligand and performs the activating function (AF2). It is also responsible for the receptor dimerization. Conservativeness reaches 59%. The function of F domain is insufficiently studied; homology of α и β isoforms does not exceed 20%.
ER activity is regulated by a number of cofac tors, which can: 1) change affinity and specificity of binding; 2) interact with other regulatory and tran scriptional factors; 3) remodel nucleosomal/chroma tin structure.
In the absence of ligands the estrogenic receptor is not active in the nucleus and connected with cell chaperons, such as the heat shock proteins (HSP90).
In the presence of ligand the estrogenic receptor gets rid of chaperons and is activated. Activated ER is phosphorylated and bound in a form of a homodimer or heterodimer with estrogenresponsible element (ERE) of the promotor site of the target genes. ERE is a palindrome sequence 5′-GGTCAnnnTGACC-3′ in DNA [11] . A spacer site nnn can contain various bases and their number may exceed three. Some de tails of ERE structure and its interaction with ER are generalized in the survey by Gruber and co-authors [12] .
AF1 and AF2 domains function with par ticipation of co-activators -cell proteins facilitate transcription. They belong to various groups: co activators of steroid receptors (SRC/P160); CREBbinding proteins (CBP); coactivator-associated ar ginine methyltransferase 1 (CARM1). Structures of these coactivators are different and they promote the transcription in different ways -acetylating his tones, methylating them or by ubiquitinylation [13] .
An important role of actin and its relative proteins in performing the transcription has been elucidated in the recent years [14] . It appeared that actinine-4 (ACTN4) takes part in realization of tran scription activity of ERα. ACTN4 and its splicing variant interact with GRIP1 (protein interacting with glucocorticoid receptor) and PCAF (a factor bound to p300/CBP) and regulate the transcription mediated by ERα [14] .
A lot of facts have been accumulated indicating that a paradigm of ER binding to ERE limits essen tially the understanding of mechanisms of ER effect on the transcription. It is known that some enhancers include only a half of ERE palindrom, while the second half is at a considerable distance [15] . Most genes contain no ERE but are activated by ER. In some cases ER bind to other transcription factors and interact with DNA through these factors.
The intracellular distribution of ER has been studied. It appears that receptors are present in the plasmatic membranes, cytosole and nuclei [16] . The membrane receptors cannot activate the transcrip tion, but can induce phosphorylation of mitogen activated proteinkinase (MAPK) when binding to estradiol. It was later shown that the receptors of another structure are also present in membranes; they transfer the estrogen signals which are not con nected with the transcription and genome [17, 18] . These nonclassical receptors are connected with Gproteins and are transmembrane receptors. A quick effect under these receptors liganding includes the release of intracellular Са 2+ and subsequent acti vation of Cacalmoduline kinases or activation of MAPK or PI3-kinase pathways. This type of recep tors was primarily called GPR30, but nowadays it is often called GPER, or GPER1. It appeared that besides plasmatic membranes, which are usually considered as the site of G-receptors distribution, it is also present in intracellular membranes [19] . The modern data on GPER function in norm and pathology are generalized in the survey by Prossnitz [20] , while the survey by Srivastava summarizes the data on its role in the nervous system [21] .
role of estrogens in physiology and pathophysiology of the brain and cardio-vascular system
The discussion of fundamental aspects of this problem became the content of a special issue of the j. Mol. Cell Endocrinol. in May 2014.
Numerous investigations have shown that es trogens take an important trophic and protective part in the brain. Epidemiological data show that the estrogen replacement therapy in women in meno pause favors the improvement of some indications of cognitive processes, protects from cognitive disturbances and decreases incidence of Alzhei mer disease [22, 23] . Estrogens decrease mortality and expression of pathologic changes under stroke [24, 25] . However, some researchers did not ob serve positive effects when using estrogens. Pos sible causes are shown in the work by Suzuki and Brown on mice [26] . They have found that E2 takes a protective effect under stroke injury, if it is used immediately after ovariectomy. Ten weeks after the operation the administration of E2 is inefficient. The longterm hypoestrogeny disturbs neuroprotective and anti-inflammatory effects of E2.
Transcriptome of the cerebral cortex was studied on ovariectomized mice which were implanted a silastic tubing ensuring physiological level of E2. Change of the transcription level of 88 genes was revealed after 7 days in the animals which received E2 as compared with castrated ones [27] . Functions of these genes are connected with cere brovascular system, growth of neurons and tissue homeostasis.
A lot of biochemical mechanisms participating in realization of the effect of estrogens in physio logical and pathophysiological processes which pro ceed in nervous tissues have been described. Some of these mechanisms are generalized in the surveys [2831] .
Neuroprotective effect of estrogens on the cell level was shown on a whole number of models. In particular, the protective effect of estradiol in vitro under the influence of β-amyloid and glutamate is shown [32, 33] . MAPK activation by estrogen recep tor is required for protection from β-amyloid [32] . It has been established that ER expression is neces sary for neurons protection from the toxical effect of glutamate [34] . The protective effect is realized both with ERE participation in gene promotor and through activation of MAPK-pathway.
Estradiol takes the neuroprotective effect under excitotoxic injuries. This effect is realized through the increase of the level of glutamate transporters expression in astrocytes, mediated by TNF-α [35] . Glutamate transporter expression in astrocytes is regulated by E2 through receptor GPR30 and in cludes various ways of signals transfer [36] . The cAMP-PKA-dependent activation of CREB as well as the pathways of EGER-PIK3-NFkB has been established. The agonist of GPR30 G1 caused the increase of expression of mRNA and protein trans porter GLT-1, accelerated glutamate capture by as trocytes in the primary culture. Allowing for the sig nificance of excitotoxicity in pathogenesis of heavy neuro-degenerative diseases, GPR30 effects are very important in development of strategy of their therapy.
Estrogens prevent in vitro the toxical effect of 6-hydroxydophamine on PC12 cells [37] . It is shown that its effect results in translocation of the nuclear transcription factor Nur77 to cytoplasm with following apoptosis, and E2 inhibits translocation and prevents apoptosis of PC12 cells.
An important way of E2 influence on the brain may be its effect on the gene which codes protein similar to neuronal epidermal growth factor [38] . This human protein is coded by two genes: NELL1 and NELL2. The authors have shown that E2 trans activate gene NELL2 through receptors α and β, and this gene mediates protective effect of E2 on culti vated neuronal cells HiB5. When affected by neuro toxins (β-amyloid or α-amino-3-hydroxy-5-methyl-4isoxazolepropionate) estradiol increased distinctly survivability of cells. After adding estradiol (10 nM) the apoptosis caused by β-amyloid, was essentially suppressed, therewith this E2 effect depends on NELL2 [38] .
Estrogens in vitro can protect cells of the hybrid line of motoneurons and neuroblastoma (vSC4.1) from injuring effect of tumor necrosis fac tor (TNF-α), which plays an important role in patho genesis of neurodegenerative diseases [39] . The au thors have supposed that low doses of ER agonists may be used in therapy of brain injuries and neuro degenerative diseases.
Estrogens take great effect on activity of the cardiovascular system. They perform a protective effect, activating signal cascades of cell defense and increasing the expression of the heat shock proteins. In experiments estradiol protects the myocardium from ischemic lesions. The mechanism of protective Огляди effect of estrogens under lesions of cardiomyocytes, observed under hypoxia/oxygenation, has been ana lyzed [40] . Urocortin and its receptor (the receptor of corticotropinreleasing hormone 2 (CRHR2)) take part in this mechanism. E2 enforces the protective effect of urocortin under hypoxia/oxygenation and increases the expression of CRHR2 in cardiomyo cytes. Consequently, the protective effect of E2 is determined by its influence on the urocortin receptor in cardiomyocytes.
The influence of estrogens on the vessels is di verse and includes quick vasodilatation, reduction of lesions of the vascular wall and inhibition of athero sclerosis development. The estrogen receptors and aromatase have been found in human blood vessels and endothelium [41, 42] . This enzyme ensures the local formation of estrogens from androgens and is broadly distributed in tissues.
Antiatherogenic effect of estrogens is preserved in mice with ERα gene knock-out [43] that is con nected with ERβ availability in the endothelium. Ac celeration of endothelium recovery after the lesion of its structure is one of the most important effects among numerous ones in the vessels. Estrogens con trol actin remodeling in the endothelial cells and de velopment of specialized membrane structures such as raffles and pseudopodia, thus inducing the cell migration [44] . These phenomena depended on the activation of moesin -a protein regulaitor of actin.
Another important factor of the membrane re modeling and motion of cells is the change of the local adhesion complex. It is shown that in the pres ence of estradiol ERα forms the Gαi/Gβ-dependent signal system which starts up the multiprotein com plex where ERα, c-Src, PI3K and focal adhesion ki nase (FAK) [45] interact. This mechanism is, probably, used in numerous processes where estrogens take a moduling part, such as remodeling of endotheliun, formation of neuronal bonds [46] , growth of cancer [47] , and development of atherosclerosis [48] . Akt activation by estrogens participates in the growth of axons and morphogenesis of neurons [49] .
It is known that the myocardium contraction energy is provided by glucose and free fatty acids. It appeared that insulin and estrogens raise the con tent of glucose transporters GLuT4 и GLuT1 in the plasmatic membrane of myocytes [50] . Under joint effect of E2 and insulin the influence on GLuT4 is enhanced.
There are data indicating a possibility of di rect influence of estrogens on the myocardium. Af ter a single E2 administration to rats the activity of Na + ,K + -ATPase, expression of α1-subunit and its phosphorylation considerably increased in the myo cardium [51] . An increase of phosphorylation of pro tein kinase В (Akt) и ERK 1/2 was noted in experi mental animals. A supposition is made on realization of E2 effect on Na + ,K + -ATPаse with participation of these systems.
oncologists give great attention to estrogens. They investigate various aspects of estrogens' biolo gy: their role in male and female cancerogenesis, analyze the use of the existing antiestrogens and search for new ones, study the mechanisms of re sistance development to antiestrogens under cancer. The elucidation of pathways of transfer of cancero genic signals in a cell as a target for tumor therapy is a new and rather promising trend [52] . Literature which clears up the importance of estrogens in on cogenesis is great and contradicting. The last to a large measure is related to existence of a variaty of receptor types and their splicing variants. The cross talking of different systems of signals transfer is of great importance. It has been found that estrogens affect the expression of microRNA that changes sig nals realization. The analysis of litrature, dedicated to oncological aspects of estrogens activity, needs a separate publication, while we will touch some prob lems concerning just the tumors of the endocrinous system.
estrogens, metabolism, endocrinous glands
All the organs and tissues of the endocrinous system belong to estrogensensitive tissues. The rela tion of estrogens and glands may be implemented at different levels, and a hypophyseal type of relation is supposedly the most known one. The formation of various tropic hormones in the hypophysis is in complex interrelations, and the change of estrogens content in the organism affects multiply the secretion of tropic compounds.
Epidemiological and prospective investigations point to a possible relation between estrogens and diabetes. ERs of both types are expressed in β-cells of Langerhans islands [53] . It is shown in experi ments with physiological concentrations of estradiol that the concentration of insulin, its secretion and insulin gene expression increase in β-cells of incu bated rat Langerhans islands, but the mass of β-cells does not change. The use of ERα and ERβ agonists as well as knockout mice has shown that the ef fect of estrogens on the pancreas is realized through ERα and ERK 1/2 signal pathway is used [53] . The same authors have further shown the participation of ERβ in regulation of the pancreatic function [54] . E2 in physiological concentrations (100 pМ -1 nМ) decreases quickly activity of ATP-dependent po tassium channels and intensifies insulin secretion by β-cells, stimulated by glucose. The given effect is mediated by ERβ. E2 in high concentrations (100 nМ -5 µМ) increases insulin secretion through GPR30. The secretion of glucagon and oscillations of Ca 2+ at low level of glucose are suppressed by E2.
Investigations on knockout mice deprived of ERα, ERβ or aromatase have shed additional light on this relation. It has been established that the re sistance to insulin is developed in male mice with knock-out of the liver receptors ERα, and realiza tion of insulin signals in the liver is disturbed. This resistance is connected with the increase of content of proteins taking part in synthesis of fatty acids and triglycerols in the liver, the decrease of glycogen for mation in the liver and increase of glucose formation under hyperinsulinemia [55] .
It is known that the skeletal muscles and white adipose tissue are of great importance in glucose ho meostasis. ERβ are mainly expressed in the skeletal muscles of mice, while ERα -in the white adipose tissue [56] . The knock-out of ERα gene causes an increase of expression of glucose transpoter GLuT4 and a fasting hypoglycaemia. The knockout of ERα leads to a decrease of GLuT4 expression both in the skeletal muscles and in the white adipose tissue. Insulin resistance was observed in these mice. The difference of expression of glucose transporter in the muscles and adipose tissue under ER knockout can explain contradictions in results of studying the ef fect of estrogens on glucose metabolism [56] .
The development of insulin resistance, the in crease of fasting blood glucose level in blood and un der glucose load, as well as the increase of the level of triglycerols and cholesterol in blood follo wing a meal are observed in mice with aromatase gene knockout [57] . Examination of patients with aro matase deficit has confirmed interrelation between estrogens and homeostasis. Patients with deficit of aromatase or ERα function suffer from the distur bance of carbohydrate metabolism, insulin resistan ce, and hyperinsulinemia. The liver function and li pid profile disorder, and liver steatosis are observed in patients with aromatase deficit. Estrogen therapy under aromatase deficit leads to improvement of metabolic indices.
It is shown on the models of diabetes of type I and 2, that E2 introduction protects the pancreas from oxidative stress and toxical effect of amyloid, lypotoxicity [58] and apoptosis. In modern opinion all the types of receptors take part in realization of E2 effects in the pancreas; that is considered in the survey by Tiano [59] . ERα stimulates insulin biosyn thesis activated by glucose and favors the survival of β-cells under the effect of proapoptotic factors. ERβ also intensifies insulin secretion activated by glucose. GPER protects β-cells from apoptosis and enhances insulin secretion, but does not affect its biosynthesis.
In vitro the selective ERβ agonist WAY200070 enhanced insulin secretion caused by glucose, hu man and mice Langerhans islands [60] . A single in jection of WAY200070 to mice leads to elevation of insulin level in the blood and improves the result of the test with glucose load. A twoweek administra tion increases the mass of β-cells in the pancreas and improves insulin sensitivity. WAY200070 improved regeneration of the mass of β-cells in mice with streptozotocin diabetes, as well as in db/db mice.
Estradiol content increases essentially in the blood of rats with streptozotocin diabetes [61] . It is evident that the increase is the result of elevation of aromatase activity, caused by the increase of the enzyme expression established, in particular, in the kidneys and retina. ERα expression also increases in the kidneys.
very interesting results have been obtained when analysing estrogens participation in preserva tion of the function of vessels under experimental diabetes [62] . ovariectomy in rats with streptozo tocin diabetes significantly decreases the expres sion of NoS3, Akt, PI3K and ERα in the aorta, and estradiol supplementation partially prevented these changes. E2 hampered a decrease of cGMP level and enhancement of iNoS expression, as well as an increase of production of No metabolites. E2 de creased considerably the content of RoS in the aorta endothelium in ovariectomized rats with diabetes. RoS content also decreased under incubation (in the presence of E2) of endothelial cells from human aor ta (line EA hy 926), treated with Н 2 О 2 . Wortmanin (PI3K inhibitor), ER antagonist ICI 182780, and Akt inhibitor hamper positive effects of E2 on cultivated cells. The results obtained have shown that adminis tration of E2 prevents downregulation of the system ERα/NoS3 in the vessels of female rats with diabe tes under deficit of endogenic hormones.
The connection of estrogens with antioxidant system has long been noted. At present there exist the data that different average lifetime of males and females, which is also characteristic of numerous animal species, is determined by antioxidant effect of estrogen hormones. It has been shown that E2 regulates the antioxidant system of the transcription factor NRF2 through the PI3K/Akt pathway [62] .
Medical investigations evidence, that patholo gy of the thyroid gland occurs more often in women largely during the period between puberty and meno pause. Thyroid carcinoma appears in women much more often than in men. ER have been found both in the normal and tumor tissue of the thyroid gland [64] , though there are works argueing the ab sence of ERα in the normal and tumor gland tissue [65] . The major publications about estrogen recep tors in the thyroid gland tissue have been generalized in the survey by Rajoria [66] . Numerous investiga tions have demonstrated that E2 can accelerate cell proliferation of the thyroid gland [67] . There are data concerning the effect of E2 on the expression of so dium/iodide simporter gene and thyroglobulin gene [67] . Stem cells from the nodes of the thyroid gland express ERα and ERβ, the expression of ERα sur passes considerably the level of expression in normal thyroid cells [68] . These data point to the participa tion of estrogens in the development of the goiter and in pathogenesis of nodule pathology.
The belief has been stated: estrogens take the opposite effect on the growth of cancer cells of the thyroid gland depending on the balance between re ceptor isoforms in the cells [69] . on this basis some authors consider the ERβ expression as a powerful differentialdiagnostic criterion for differentiation of adenomas and follicular thyroid carcinomas [70] . The authors think that low ERβ expression is a bad prognostic index under the follicular thyroid carci nomas.
ERα and ERβ have been found in the tissue of human medullary thyroid carcinoma [71] , but ERβ expression was observed more rarely. The role of these receptors has been analyzed on the cell culture of TT line of the medullary carcinoma of this gland. After ER-negative ТТ-cells were treated by the ade novirus vector carrying ER, this receptor functioned in the cells activating EREmediated gene response. However, the proliferation and apoptosis were reali zed differently, depending on the ER type. In the presence of estrogens ERα functioned as growth stimulator, while ERβ worked as growth inhibitor, independent of estrogen effect. It has been shown that for genes regulating apoptosis and cell cycle the transfer of estrogen signals may be performed on the pathway which does not use ERE [71] . The opinion is advanced that the modulation of these receptors and the influence on the transfer of their signals are potential trends of the therapy of thyroid carcinoma [72] .
The effect of estrogens was studied in vitro on the cells of papillary carcinoma (KAT5), follicular carcinoma (FRo), and anaplastic carcinoma (ARo) from the thyroid gland [73] . Estradiol stimulated proliferation. ERα agonist stimulated growth and proliferation, increased expression of Bcl2 and in creased the level of phosphorylated ERK 1/2. This indicates the positive role of ERK 1/2 in cell proliferation caused by E2. ERα knock-out inhibited the above effects of E2, while ERβ knock-out strengthened them [73] . Evidently, it is ERβ that takes part in the cell apoptosis of the thyrois gland. E2 and plant estrogen genistein caused proliferation of the cells of thyroid carcinoma of WRo, FRo and ARo lines. The actuation of genes regulating the cell cycle and proliferation of thyrois cells is mediated by GPR30 and MAP-kinase cascade [74] . Activation of growth of ARo cells having no ERα is additional corrobora tion of GPR30 participation in realization of estro gens' effect. The following sequence of events has been offered to implement E2 effect in the tumor cells of thyroid carcinoma: 1) quick activation of MAPK; 2) induction of c-fos and cyclines A and D1;
3) cell growth [74] . It has been established that E2 increases the expression of cyclines А и D1 in dif feent type tumor cells of the thyroid gland [7476] .
It is known that the level of peroxysome pro liferator-activated receptor γ (PPARγ) is decresed in the cells of thyroid carcinoma. It appeared that PPARγ и ERα in terms of the function are in the feedback in the tumor cells [77] . Rosiglitazone -PPARγ agonist -causes a decrease of ERα expres sion in the cells of papillary and anaplastic cancer. ER knockdown with microRNA resulted in the in crease of expression of protein PPARγ, ER expres sion increased under PPARγ blockade. Rosiglitazone prevented proliferative activity of ERα, but increased ERβ ability to decrease proliferation and migration of cancer cells. The obtained results evidence for the presence of negative feedback in ERα and PPARγ. But ERβ and PPARγ jointly possess the inhibitory effect on proliferation and migration of cells of papil lary thyroid cancer [77] .
A possible role of estrogens in tumor meta static propensity was investigated on cultivated cells of papillary cancer of the thyroid gland of BCPAP line [78] . It was found out that estradiol can increase the ability of these cells to metastatic propensity and invasion by estimates in vitro. The authors have es tablished that the expression of Е-cadherine in BC PAP cells decreases considerably under the effect of E2 and ERα agonist. Therewith the expression of vimentin and matrix metalloproteinase-9 (MMP-9) increased. In contrast, ERβ agonist caused a con siderable increase of the expression of Ecadherine, while the expression of vimentin and MMP-9 lowred. These data evidence that in the thyroid gland ER subtypes play different role in carcinogenesis.
A decrease or absence of Ecadherine is shown in the cells of anaplastic cancer of the thyroid gland characterized by mesenchimal phenotype [79] . The authors have studied the effect of histone deacety lase inhibition on the expression of Ecadherine, cell migration and invasiveness. The investigations were conducted on three lines of cell cultures, primary culture and xenotransplants in mice. Inhibition of histone deacetylase induces the expression of E cadherine. The complex E-cadherine/β-catenine is adequately localized in the cell membrane, and the ability to cell migration and invasion decreases.
The estrogen receptors have been found in the adrenals as in the other endocrine glands. The estro gen receptors were also investigated in the human adrenal cortex and aldosteronomas [80] . It appeared that the basic estrogen receptors in these tissues are ERβ and GPER-1, respectively, though ERα is also expressed. After ERβ blockade by specific blocators, estradiol in vitro increased 57 times the expression of aldosterone synthase (CYP11B2) (EC 1. 14.15.4) and formation of aldosterone by HAC 15 cells from human aldosteronoma. Agonist GPER-1 reproduced the given effect, but the antagonist GPER-1 and in hibitor of protein kinase A blocked the effect of E2. These data show that E2 through ERβ can inhibit aldosterone synthesis in human adrenals, but under ERβ blockade estradiol stimulates aldosterone for mation through GPER-1 and protein kinase А.
But even before detecting the specific receptors it was established that the estrogen hormones acti vate synthesis of corticosteroid hormones E2 stimulated formation of 11hydroxycorticos teroids in the primary culture of adrenocortical cells of pigs. This effect depended on E2 concentration [81] . The incorporation of 3 Н-thymidine into DNA is enhanced in parallel. Hormones formation in the human adrenal slices increased more than 2.5 times in the presence of E2 [82] . The castration of male rats reduced considerably the content of 11hydroxy corticosteroids in the blood plasma [83] . Threeday administration of E2 raised considerably the concen tration of 11hydroxycorticosteroids in the blood of both intact and orchiectomized animals.
Activation mechanism of adrenocortical func tion proved to be rather complex. ovariectomy in rats caused a considerable decrease of specific binding of the labeled adrenocorticotropic hormone by the adrenal cortex microsomas [84] . Threeday E2 administration to ovariectomized rats raised ACTH binding up to the values in excess of the binding in control animals. The number of binding sites of highly affine and low affine receptors in creased. The E2 administration to ovariectomized rats raised considerably the inclusion of labelled cho lesterol into corticosterone -the principal adreno cortical hormone in rats [85] . An analogous but less expressed effect was traced on intact females.
It has long been established that the stimulating effect of ACTH on steroidogenesis in the adrenals is mediated by cAMP. Incubation of the human adrenal slices in the presence of E2 caused an increase of cAMP content, which began 1 hour after and con tinued to about the 4 th hour [86] . Maximum level of cAMP exceeded 7 times the initial indices [87] . Administration of E2 to castrated male rats raised almost 2 times the activity of cAMP-depended pro teinkinase A (PKA) in cytosol fraction of the adre nal cortex and more than 1.6 times -in microsomal fraction [83] . Analogous changes were also observed in the adrenals of intact animals. In vitro E2 acti vated PKA in the microsomal fraction of human ad renal slices [87] .
However PKA has not proved to be the only protein kinase activated by estrogens in this gland. The increase of activity of protein kinase C (PKC) has been established in the adrenal tissue of intact and castrated male rats which received E2 during three days [83] . Analogous results were obtained under incubation of human adrenal slices [83, 84] . The fact of the estrogens effect in the adrenal glands on protein kinases, activated by mitogens -MAPkinases, is of extreme interest. As a result of E2 ad ministration to rats for three days the expression of ERK 1/2, estimated with the help of western-blot ting, increases in the adrenals 1.7 times [85] . The content of p38 and JNK did not change under these Огляди conditions. Determination of cfos expression has shown a 1.8fold dosedependent increase of protein level under administration of 100 µg of E2 [85, 86] . But the expression of cjun did not change in these experiments.
When analyzing a direct effect of estrogens on formation of corticosteroids, we have studied the change of expression of cytochrome P450scc (1.14.15.6) -the key steroidogenesis enzyme and steroido genic acute regulatory protein (StAR). The incubation of human adrenal cortex slices in the presence of E2 elevated the expression lev el of mRNA of cytochrome P450scc and StAR in adrenocorticocytes by 38 and 79%, respectively, as compared to control [90] . It is significant that after cholesterol transfer inside the adrenal mitochondria StAR molecule loses its ability of repeated transfers because of splittingoff the signal fragment. This determines a necessity of continuous synthesis of StAR.
There are numerous data on antiapoptotic ef fects of estrogens. The antiapoptotic effect of E2 in vitro is shown in the cells of skeletal muscles С2С12 [91] . Cytoskeleton damages, picnotic and fragmented nuclei are found under treatment of these cells with Н 2 О 2 . The preliminary treatment with E2 (10 8 М) prevents these changes of apoptotic character, but the inhibitors ERK and p38 block E2 effects. These results show that E2 supports the survival of cells of the skeletal muscles using the activation of ERK и p38 МАРК [91] . It has been established that E2 can activate ERK and then induce its translocation into mitochondria [92] . Therewith the activity of cyto chrome oxidase complex Iv increases. E2 prevents Ways of estrogen effect realization in the adrenals. GPEr -G-protein-coupled estrogen receptor; Er -nuclear receptor of estrogens; StAr -steroidogenic acute regulatory protein; P450scc -sidechain cleavage enzyme; MAPk -mitogen-activated proteinkinase; Bax -proapoptosis regulator; PkA -protein kinase A; PkC -protein kinase C the collaps of mitochondrial potential caused by Н 2 О 2 . Such is the mechanism of antiapoptotic effect of E2 in the authors' opinion.
various effects of estrogens, connected with proliferation and apoptosis, are realized in the adre nal tissue: the content of DNA and RNA increases as a result of E2 administration to male rats [93] . un der the incubation of slices of conventionally normal tissue of human adrenal glands with E2, the level of mRNA of protein Bax decreased and apoptotic fragmentation of DNA was essentially inhibited [94] . These facts permit us to think that estrogens take the antiapoptotic effect in the adrenal tissue as in many other tissues. The main ways of estrogens effect on the adrenals are presented in the Figure. Completing a brief survey of estrogens' bio chemical effects it should be said that these com pounds are universal participants of metabolism regulation processes. They display activity in practi cally all organs and systems both in norm and under pathology. 
